Home
Kynam Capital Management reported a 8.77% stake in Celldex Therapeutics CLDX · 0 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 8.77%
- Last report
- 9.79% · filed 25/05/15
- Shares held
- 0 sh
- Class
- Common Stock, par value $0.001
- Holder
- Kynam Capital Management
- Event date
- 26/03/31
- Filed
- 26/05/15
8.77% stake · −1.0pp from the last report
- Stake
- 8.77%
- Last report
- 9.79%
- Since last report
- −1.0pp
Celldex Therapeutics trades, last 26 weeks
What else happened in Celldex Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Kynam Capital Management's other 5% stake reports
- Kynam Capital Management
5% stakeViridian Therapeutics, Inc.\DE
5% stakeViridian Therapeutics, Inc.\DE
VRDN
5.7% stake
0 sh
5.7% stake
Filed 08/14
- Kynam Capital Management
5% stakeVera Therapeutics
5% stakeVera Therapeutics
VERA
4.01% stake
0 sh
4.01% stake
Filed 08/14
- Kynam Capital Management
5% stakeCytomX Therapeutics
5% stakeCytomX Therapeutics
CTMX
9.96% stake
0 sh
9.96% stake
Filed 08/14
- Kynam Capital Management
5% stakeCelldex Therapeutics
5% stakeCelldex Therapeutics
CLDX
6.78% stake
0 sh
6.78% stake
Filed 08/14
- Kynam Capital Management
5% stakeBurning Rock Biotech
5% stakeBurning Rock Biotech
BNR
13.97% stake
0 sh
13.97% stake
Filed 05/15
